{"transactions":[{"id":1086685,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":77482,"kind":"person","name":"Brownstein Carrie","position":1,"cik":"0001894232","reported_name":"Brownstein Carrie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-16T16:13:31.000Z","date":"2025-07-14","kind":"grant","planned":false,"acquired":true,"shares":33150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 33,150 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":33150,"derivative":{"exercise_price":0.82,"expiration_date":"2035-07-14","underlying":"Common Stock","underlying_shares":33150},"source":{"system":"sec-edgar","filing":"0000950170-25-096266","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894232/000095017025096266/ownership.xml","form_type":"4"}},{"id":1472262,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":77482,"kind":"person","name":"Brownstein Carrie","position":1,"cik":"0001894232","reported_name":"Brownstein Carrie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T17:59:50.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":27700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 27,700 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":27700,"derivative":{"exercise_price":4.37,"expiration_date":"2034-06-21","underlying":"Common Stock","underlying_shares":27700},"source":{"system":"sec-edgar","filing":"0000950170-24-076378","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894232/000095017024076378/ownership.xml","form_type":"4"}},{"id":1763806,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":77482,"kind":"person","name":"Brownstein Carrie","position":1,"cik":"0001894232","reported_name":"Brownstein Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-10-06T19:19:49.000Z","date":"2023-10-04","kind":"sale","planned":true,"acquired":false,"shares":1722,"price":19.9102,"value":34285.3644,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $19.91 to $19.93. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":105685,"source":{"system":"sec-edgar","filing":"0001725160-23-000181","document":"wk-form4_1696634381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894232/000172516023000181/wk-form4_1696634381.xml","form_type":"4"}},{"id":1763805,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":77482,"kind":"person","name":"Brownstein Carrie","position":1,"cik":"0001894232","reported_name":"Brownstein Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-10-06T19:19:49.000Z","date":"2023-10-04","kind":"sale","planned":true,"acquired":false,"shares":8906,"price":19.4265,"value":173012.409,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $18.91 to $19.90. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":107407,"source":{"system":"sec-edgar","filing":"0001725160-23-000181","document":"wk-form4_1696634381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894232/000172516023000181/wk-form4_1696634381.xml","form_type":"4"}},{"id":1873501,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":77482,"kind":"person","name":"Brownstein Carrie","position":1,"cik":"0001894232","reported_name":"Brownstein Carrie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-31T16:36:32.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":40258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":40258,"derivative":{"exercise_price":2.72,"expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":40258},"source":{"system":"sec-edgar","filing":"0000950170-23-025368","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894232/000095017023025368/ownership.xml","form_type":"4"}},{"id":2038734,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":77482,"kind":"person","name":"Brownstein Carrie","position":1,"cik":"0001894232","reported_name":"Brownstein Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-01T19:06:07.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":23687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date."}],"balance_after":23687,"derivative":{"exercise_price":23.65,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":23687},"source":{"system":"sec-edgar","filing":"0001725160-23-000015","document":"wf-form4_167529635221236.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894232/000172516023000015/wf-form4_167529635221236.xml","form_type":"4"}},{"id":2038733,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":77482,"kind":"person","name":"Brownstein Carrie","position":1,"cik":"0001894232","reported_name":"Brownstein Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-01T19:06:07.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":16313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date."}],"balance_after":116313,"source":{"system":"sec-edgar","filing":"0001725160-23-000015","document":"wf-form4_167529635221236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894232/000172516023000015/wf-form4_167529635221236.xml","form_type":"4"}},{"id":2147637,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":77482,"kind":"person","name":"Brownstein Carrie","position":1,"cik":"0001894232","reported_name":"Brownstein Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-03T18:37:53.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options were granted by the Issuer under the 2022 Inducement Plan as an inducement material to the Reporting Person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest as to 100% of the shares on the earlier of (a) FDA approval of a Zentalis product or (b) a Change in Control (as defined in the 2022 Inducement Plan)."}],"balance_after":100000,"derivative":{"exercise_price":22.21,"expiration_date":"2032-10-02","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001725160-22-000178","document":"wf-form4_166483658913178.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1894232/000172516022000178/wf-form4_166483658913178.xml","form_type":"4"}},{"id":2147636,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":77482,"kind":"person","name":"Brownstein Carrie","position":1,"cik":"0001894232","reported_name":"Brownstein Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-03T18:37:53.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted by the Issuer under the 2022 Inducement Plan as an inducement material to the Reporting Person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":300000,"derivative":{"exercise_price":22.21,"expiration_date":"2032-10-02","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001725160-22-000178","document":"wf-form4_166483658913178.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894232/000172516022000178/wf-form4_166483658913178.xml","form_type":"4"}},{"id":2147635,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":77482,"kind":"person","name":"Brownstein Carrie","position":1,"cik":"0001894232","reported_name":"Brownstein Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-10-03T18:37:53.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted by the Issuer under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (the \"2022 Inducement Plan\") as an inducement material to the Reporting Person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years: 25% of the RSUs will vest on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001725160-22-000178","document":"wf-form4_166483658913178.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894232/000172516022000178/wf-form4_166483658913178.xml","form_type":"4"}},{"id":2236426,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":77482,"kind":"person","name":"Brownstein Carrie","position":1,"cik":"0001894232","reported_name":"Brownstein Carrie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T16:31:17.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":40258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":40258,"derivative":{"exercise_price":4.32,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":40258},"source":{"system":"sec-edgar","filing":"0000899243-22-021924","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894232/000089924322021924/doc4.xml","form_type":"4"}},{"id":2508013,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":77482,"kind":"person","name":"Brownstein Carrie","position":1,"cik":"0001894232","reported_name":"Brownstein Carrie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-17T16:10:20.000Z","date":"2021-11-12","kind":"grant","acquired":true,"shares":10467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 10,467 shares of the Issuer's common stock, which will vest in three equal annual installments on each of the first three anniversaries of October 22, 2021, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":10467,"derivative":{"exercise_price":19.27,"expiration_date":"2031-11-12","underlying":"Common Stock","underlying_shares":10467},"source":{"system":"sec-edgar","filing":"0000899243-21-045053","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894232/000089924321045053/doc4.xml","form_type":"4"}}]}